Literature DB >> 8217437

Antiarrhythmic drugs in the management of atrial fibrillation.

J C Cowan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217437      PMCID: PMC1025324          DOI: 10.1136/hrt.70.4.304

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  28 in total

Review 1.  Non-rheumatic atrial fibrillation: warfarin or aspirin for all?

Authors:  J Nolan; P Bloomfield
Journal:  Br Heart J       Date:  1992-12

2.  A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction.

Authors:  J C Cowan; P Gardiner; D S Reid; D J Newell; R W Campbell
Journal:  J Cardiovasc Pharmacol       Date:  1986 Mar-Apr       Impact factor: 3.105

Review 3.  Antiarrhythmic drug effects on left ventricular performance.

Authors:  J P Bourke; J C Cowan; S Tansuphaswadikul; R W Campbell
Journal:  Eur Heart J       Date:  1987-03       Impact factor: 29.983

4.  Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.

Authors:  A O Molajo; M O Coupe; D H Bennett
Journal:  Br Heart J       Date:  1984-10

5.  Efficacy of i.v. amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients.

Authors:  R Faniel; P Schoenfeld
Journal:  Eur Heart J       Date:  1983-03       Impact factor: 29.983

6.  Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.

Authors:  A W Nathan; A J Camm; R S Bexton; K J Hellestrand
Journal:  Clin Cardiol       Date:  1987-05       Impact factor: 2.882

7.  Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.

Authors:  R DiBianco; J Morganroth; J A Freitag; J A Ronan; K M Lindgren; D J Donohue; L J Larca; K D Chadda; A Y Olukotun
Journal:  Am Heart J       Date:  1984-10       Impact factor: 4.749

8.  Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial.

Authors:  R H Falk; A A Knowlton; S A Bernard; N E Gotlieb; N J Battinelli
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

9.  Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.

Authors:  J E Atwood; M Sullivan; S Forbes; J Myers; W Pewen; H G Olson; V F Froelicher
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

Review 10.  Physiological pacing: present status and future developments.

Authors:  A Wirtzfeld; G Schmidt; F C Himmler; K Stangl
Journal:  Pacing Clin Electrophysiol       Date:  1987-01       Impact factor: 1.976

View more
  4 in total

Review 1.  Pharmacological control of rate and maintenance of sinus rhythm.

Authors:  M D Ezekowitz; R Lampert
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 2.  ABC of atrial fibrillation. Drugs for atrial fibrillation.

Authors:  G Y Lip; R D Watson; S P Singh
Journal:  BMJ       Date:  1995-12-16

3.  Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.

Authors:  F Bellandi; R P Dabizzi; F Cantini; M D Natale; L Niccoli
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

4.  Distribution of fast heart rate episodes during paroxysmal atrial fibrillation.

Authors:  K Hnatkova; F D Murgatroyd; C A Alferness; A J Camm; M Malik
Journal:  Heart       Date:  1998-05       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.